News
Schering-Plough Zetia, the first in a new class of cholesterol-lowering drugs that slow intestinal absorption of cholesterol has gained FDA approval.
The ABPI Scottish Diabetes Industry Group (SDIG) and the Scottish Executive have collaborated on a new website to raise public awareness of the...
Workers throughout the NHS are to receive substantial pay rises in return for undergoing radical ob evaluationreviews over the next three years.
Novartis has submitted its COX-II inhibitor Prexige to US and European regulators with data from 13,000 clinical trial patients to prove its safety...
Thousands of trained pharmacists and nurses will be able to prescribe drugs for chronic diseases by late 2004, the Government has announced.
Pharmaceutical companies must make their sales and marketing more cost-effective or cut back, according to a new report.
Oxford GlycoSciences has announced the EU approval of its first product, Zavesca, and an extension to its co-marketing agreement with Actelion.
New measures intended to improve the competitiveness of clinical trials in Europe could have the opposite effect, a leading research head has warned.
GlaxoSmithKline's Chief Executive Jean-Pierre Garnier is to back down on demands for a hugely increased pay package after fierce criticism from...